Retinopathy of Prematurity in Infants Born before 25 Weeks Gestation in a Korean Single Neonatal Intensive Care Unit: Incidence, Natural History and Risk Factors

다국어 초록 (Multilingual Abstract)

As younger preterm infants are able to survive, more extremely preterm infants are at risk of developing retinopathy of prematurity (ROP). To investigate the incidence, progression and risk factors of ROP in extremely preterm infants in Korea, the medical records of infants born before 25 weeks gestation were retrospectively reviewed. The criteria for laser treatment agreed with type 1 ROP as defined by the Early Treatment for Retinopathy of Prematurity study. Of the 121 infants included in the analysis, 119 (98.4%) infants developed any stage ROP, including 78 infants (64.5%) with type 1 ROP. The mean postmenstrual age (PMA) at the onset of any ROP and type 1 ROP were 33.5 and 36.1weeks, respectively. All but one infant developed type 1 ROP after 31 weeks PMA.

Univariate analysis showed that duration of total parenteral nutrition and onset of any ROP (PMA) were associated with the development of type 1 ROP. In conclusion, this study shows high incidence of ROP in extremely preterm infants and suggests that, although current screening protocols are feasible for most preterm infants born before 25 weeks gestation, earlier screening before 31 weeks PMA may be necessary in infants with an unstable clinical course.

참고문헌 (Reference)

1 Wilkinson AR, "UK retinopathy of prematurity guideline" 23 : 2137-2139, 2009

2 Tan SZ, "Trends in the incidence of retinopathy of prematurity in Lothian, south-east Scotland, from 1990 to 2009" 97 : F310-F311, 2012

3 Austeng D, "Treatment for retinopathy of prematurity in infants born before 27 weeks of gestation in Sweden" 94 : 1136-1139, 2010

4 International Committee for the Classification of Retinopathy of Prematurity, "The international classification of retinopathy of prematurity revisited" 123 : 991-999, 2005

5 Good WV, "The Early Treatment for Retinopathy of Prematurity Study: structural findings at age 2 years" 90 : 1378-1382, 2006

6 Austeng D, "Screening for retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden" 129 : 167-172, 2011

7 Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus, "Screening examination of premature infants for retinopathy of prematurity" 117 : 572-576, 2006

8 Early Treatment For Retinopathy Of Prematurity Cooperative Group, "Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial" 121 : 1684-1694, 2003

9 Gilbert C, "Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control" 84 : 77-82, 2008

10 Lad EM, "Retinopathy of prematurity in the United States" 92 : 320-325, 2008

11 Teed RG, "Retinopathy of prematurity in extremely premature infants" 13 : 370-373, 2009

12 Schaffer DB, "Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group" 100 : 230-237, 1993

13 Muether PS, "No advanced retinopathy of prematurity stages 4 or 5 in a large high-risk German cohort" 96 : 400-404, 2012

14 Stoll BJ, "Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network" 126 : 443-456, 2010

15 Austeng D, "Natural history of retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden" 128 : 1289-1294, 2010

16 Shah VA, "Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore" 34 : 169-178, 2005

17 Austeng D, "Incidence of retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden" 127 : 1315-1319, 2009

18 Gunn DJ, "Incidence of retinopathy of prematurity in extremely premature infants over an 18-year period" 40 : 93-99, 2012

19 Palmer EA, "Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group" 98 : 1628-1640, 1991

20 Wilson-Costello D, "Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s" 115 : 997-1003, 2005

21 Good WV, "Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial" 102 : 233-248, 2004

22 Slidsborg C, "Experts do not agree when to treat retinopathy of prematurity based on plus disease" 96 : 549-553, 2012

23 Can E, "Effects of aggressive parenteral nutrition on growth and clinical outcome in preterm infants" 2012

24 Good WV, "Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study" 116 : 15-23, 2005

25 Hussain N, "Current incidence of retinopathy of prematurity, 1989-1997" 104 : e26-, 1999

26 Gilbert C, "Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs" 115 : e518-e525, 2005